How do you pay?

How to pay the least

Ask for the cash price

Twirla

No generic is sold yet.

  1. Ask your pharmacy for Twirla’s cash price, and one or two other pharmacies too.
  2. Twirla’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameTwirla
Authorized genericlevonorgestrel and ethinyl estradiol
Regular genericlevonorgestrel and ethinyl estradiol
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone sold yet
Same as Twirla?
The original
–
–

Brand nameThe maker’s card

Twirla Patient Savings Program

Savings card from Agile Therapeutics

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $25 a fill

Print the card (PDF) 

Or text TWIRLA to 31700. See the offer on twirla.com

In the maker’s words

“As a Twirla patient, you may be eligible to pay as little as $25 per 1– or 3–month prescription fill (a 3 month fill may cost patients $8.33 per month).”

From the maker’s offer on twirla.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Twirla itself, from the same company, sold without the brand name, and usually for less. For now Twirla is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

TWIRLA is a combination of levonorgestrel, a progestin, and ethinyl estradiol, an estrogen, indicated as a method of contraception for use in women of reproductive potential with a BMI < 30 kg/m 2for whom a combined hormonal contraceptive is appropriate.

Limitation of Use Consider TWIRLA’s reduced effectiveness in women with a BMI ≥ 25 to < 30 kg/m 2before prescribing.

Source: the FDA label for Twirla (Agile Therapeutics, Inc.), June 30, 2026. Full label on DailyMed 

Good to know